Research dossier

MOTS-c — mitochondrial-derived peptide dossier

One of the few peptides encoded by the mitochondrial genome rather than by nuclear DNA.

7 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

MOTS-c — research dossier illustration

Molecular identity

ParameterValue
CAS number1627580-64-6
Molar mass2174.6 g/mol
Molecular formulaC₁₀₁H₁₅₂N₂₈O₂₂S₂
Sequence / natureMet-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
Purity≥99%
AppearanceWhite lyophilised powder

The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.

Research context

The existence of peptides encoded by the mitochondrial genome changed the understanding of the dialogue between mitochondrion and nucleus. MOTS-c is the best studied representative of that family, and its scientific interest goes beyond its own properties: it serves as a demonstration of a retrograde communication mechanism that was long hypothetical.

Mechanism studied

MOTS-c belongs to a small family of so-called mitochondrial-derived peptides: its sequence is encoded in the mitochondrial genome itself, within the 12S ribosomal RNA gene, and not in nuclear DNA. That peculiarity makes it an object of study distinct from the classical signalling peptides.

The mechanism best documented in vitro concerns the folate cycle and the methionine pathway. Work in culture has reported an accumulation of AICAR, an intermediate in purine biosynthesis, whose described consequence is activation of AMPK (AMP-activated protein kinase) — the cell’s sensor of energy status.

AMPK is studied as a point of metabolic convergence: its activation is associated in the literature with modulation of glucose utilisation and fatty acid oxidation in cell systems. The measurements reported rest on AMPK phosphorylation at Thr172, detected by western blot, and on radiolabelled glucose uptake assays.

In-vitro literature

The publications concern mainly cultured myotubes and hepatic cell lines. The question of nuclear translocation of the peptide under metabolic stress is addressed in several studies, using immunofluorescence and subcellular fractionation methodologies.

Bibliographic entry points

These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.

Distinguishing this compound from its analogues

To be distinguished from the other mitochondrial-derived peptides described (humanin and small open reading frame peptides from the same locus), whose sequences and reported mechanisms differ.

The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.

Methodological limits

The mitochondrial origin of the peptide means the genetic code used differs from the nuclear code, a peculiarity to account for in any recombinant expression approach. In culture, AMPK activation is a very broad point of convergence: many stimuli trigger it, and observing it alone does not demonstrate a mechanism specific to the compound.

These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.

Analytical parameters

A 16 amino acid peptide, with no post-translational modification. The chromatographic profile is clean and synthesis impurities are well resolved.

ParameterValue
StorageStore at −20 °C, protected from light
SolubilitySoluble in bacteriostatic water (BAC)
StabilityStable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C
Control methodsRP-HPLC · MS · NMR

Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.

Resulting concentrations

The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.

Format1 ml2 ml3 ml
10mg10.00 mg/ml5.00 mg/ml3.33 mg/ml
40mg40.00 mg/ml20.00 mg/ml13.33 mg/ml

These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.

Protocol design

Three points govern the validity of an assay using this material, whatever the question being asked.

The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.

The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.

The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.

Lot verification

The following formats are covered by a Janoshik Analytical report, readable from the product page:

  • 10mg — lot report available
  • 40mg — lot report available
FormatLot reportAvailability
10mgCoveredIn stock
40mgCoveredIn stock

The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.

Frequently asked questions

How does this product arrive?

As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.

Which solvent should be used for reconstitution?

Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.

How long does the material remain stable?

The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.

Does the analysis report correspond exactly to my vial?

The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.

Can this product be used on humans or animals?

No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.

Dossiers in the same category

Related dossiers

All research dossiers → · Catalogue → · Glossary →